First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2027 revenue reaching $1.1B — +24.0% growth in a single year.
What Moves the Stock
1US federal cannabis legislation progress (SAFE Banking Act, rescheduling from Schedule I to III, state-level legalization momentum) - any positive regulatory news drives 20-40% single-day moves
2Canadian cannabis market pricing trends and provincial wholesale rate changes - further price compression accelerates cash burn
3European medical cannabis reimbursement expansion (Germany's April 2024 partial legalization implementation, UK NHS coverage decisions)
4Equity dilution risk and liquidity events - company has raised capital via ATM offerings multiple times, diluting shareholders by 30%+ since 2021
6Canadian recreational cannabis (~40-45% of revenue): dried flower, pre-rolls, vapes, edibles sold through provincial distributors under brands like Broken Coast, Good Supply
7International medical cannabis (~25-30%): Germany, UK, Australia, Israel distribution of medical cannabis products, primarily wholesale
8Beverage alcohol (~20-25%): craft beer and ready-to-drink products through SweetWater (Georgia), Montauk (New York), Breckenridge Distillery brands
Speculative growth/momentum - Stock attracts retail investors betting on US federal legalization catalyst and institutional short-sellers…
High sensitivity through multiple channels: (1) $160M debt load faces refinancing risk if rates remain elevated - current 0.20 debt/equity…
Watch on earnings: US congressional cannabis legislation calendar and DEA rescheduling timeline (Schedule III reclassification would allow tax deductions, improving economics by 20-30%), Canadian provincial wholesale cannabis pricing per gram (Ontario Cannabis Store benchmark pricing), Tilray monthly cash balance and quarterly operating cash flow burn rate.
One Sentence Summary:
Tilray Brands: the story is balanced — us federal cannabis legislation progress (safe banking act, rescheduling from schedule i to iii.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.